a day ago
LLY
AnalystsChris SchottChris Schott's Stock Forecasts
AnalystsChris Schott
Analyst Ranking
Top 12%
#653 out of 5523 analysts
Average Return
+10.89%
Win Rate
62%62 out of 100
Risk vs Reward
Poor
Good
Chris Schott's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Teva Pharmaceutical Industries LtdTEVA | +99.55% | $17.96 | $35.84 | 2025-05-12 - 2026-05-11 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +94.30% | $20.01 | $38.88 | 2025-10-03 - 2026-09-28 | Strong Buy |
Eli Lilly & CoLLY | +89.52% | $625.65 | $1,185.71 | 2025-08-08 - 2026-08-07 | Strong Buy |
Eli Lilly & CoLLY | +85.30% | $395.86 | $733.51 | 2023-04-28 - 2024-04-26 | Strong Buy |
Eli Lilly & CoLLY | +75.50% | $458.48 | $804.62 | 2023-07-28 - 2024-07-26 | Strong Buy |
Chris Schott Analyst Color
Get additional color on Chris Schott's coverage of popular stocks
3 months ago
ABBV
3 months ago
LLY
8 months ago
LLY
9 months ago
TEVA
10 months ago
LLY
a year ago
TEVA
a year ago
ABBV
a year ago
GILD
a year ago
TEVA
a year ago
GILD
a year ago
LLY
a year ago
AMRX
a year ago
ABBV
a year ago
LLY
a year ago
IDXX
a year ago
TEVA
2 years ago
AMRX
2 years ago
LLY
2 years ago
LLY
3 years ago
LLY
3 years ago
PFE
3 years ago
LLY
3 years ago
LLY
3 years ago
LLY
Chris Schott's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eli Lilly & CoLLY | 20 | Strong Buy | $1,500.00 | +26.61% | Maintains | a day ago |
Amneal Pharmaceuticals IncAMRX | 4 | Strong Buy | $22.00 | +7.32% | Reinstates | a month ago |
Zoetis IncZTS | 5 | Strong Buy | $115.00 | +61.00% | Maintains | 2 months ago |
Royalty Pharma PLCRPRX | 6 | Strong Buy | $62.00 | +6.22% | Maintains | 2 months ago |
Bristol Myers Squibb CoBMY | 2 | Strong Buy | $73.00 | +14.28% | Maintains | 2 months ago |
Merck & Co IncMRK | 6 | Strong Buy | $140.00 | -5.84% | Maintains | 3 months ago |
Abbvie IncABBV | 5 | Strong Buy | $280.00 | +5.15% | Maintains | 3 months ago |
Pfizer IncPFE | 4 | Hold | $28.00 | -2.51% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 10 | Strong Buy | $850.00 | +12.99% | Maintains | 4 months ago |
Viatris IncVTRS | 3 | Hold | $18.00 | -1.48% | Maintains | 5 months ago |
Elanco Animal Health IncELAN | 6 | Strong Buy | $30.00 | +33.63% | Maintains | 5 months ago |
Teva Pharmaceutical Industries LtdTEVA | 11 | Strong Buy | $40.00 | +2.88% | Maintains | 5 months ago |
Johnson & JohnsonJNJ | 1 | Hold | $250.00 | -8.07% | Maintains | 7 months ago |
Perrigo Co PLCPRGO | 7 | Hold | $18.00 | +19.21% | Maintains | 9 months ago |
Organon & CoOGN | 3 | Strong Sell | $12.00 | -12.60% | Maintains | a year ago |
Idexx Laboratories IncIDXX | 9 | Strong Buy | $775.00 | +46.49% | Maintains | a year ago |
Gilead Sciences IncGILD | 8 | Strong Buy | $150.00 | -1.45% | Maintains | a year ago |
Biogen IncBIIB | 4 | Hold | $175.00 | N/A | Maintains | a year ago |
Amgen IncAMGN | 1 | Hold | $270.00 | N/A | Reinstates | 3 years ago |
Coherus Oncology IncCHRS | 2 | Hold | $11.00 | N/A | Maintains | 4 years ago |
Eqrx IncEQRX | 2 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Heska CorpHSKA | 2 | Strong Buy | $150.00 | N/A | Maintains | 4 years ago |
Bausch Health Companies IncBHC | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 6 years ago |
Kala Bio IncKALA | 4 | Strong Buy | $47,500.00 | N/A | Maintains | 6 years ago |
Therapeuticsmd IncTXMD | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Endo International PLCENDPQ | 2 | Hold | $10.00 | N/A | Maintains | 8 years ago |
Pacira Biosciences IncPCRX | 2 | Hold | $50.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.